Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Bladder Cancer treatment details. Chemotherapy. Hormone. Massachusetts General Hospital, Boston, MA, United States

Survival: 9.6 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Pemetrexed
Country: United States
City/State/Province: Boston, MA
Hospital: Massachusetts General Hospital
Journal: Link
Date: 7/2006

This phase II study involved 47 patients with transitional cell cancer of the urothelium, a type of bladder cancer, who had received prior chemotherapy. The median patient age was 64 years and 80.9% were male.

Patients were treated with the chemotherapy agent pemetrexed. Patients also received prophylactic care with folic acid and B12 vitamins and with the steroid dexamethasone.

The most severe adverse events were of grade 4 and included leukopenia and neutropenia.

The reported median overall survival was 9.6 months.

This study was supported by the pharmaceutical company Eli Lilly.

Correspondence: Dr. Donald S. Kaufman; email:

E-mail to a Friend Email Physician More Information